🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well nemtabrutinib works with rituximab for t...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-01-22
Trial ID
NCT06572618
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
This phase II trial investigates the how well acalabrutinib and obinutuzuma...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-08-25
Trial ID
NCT04505254
Treatments Being Tested
This phase II trial studies how well acalabrutinib and venetoclax with or w...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-07-29
Trial ID
NCT04169737
Treatments Being Tested
This phase II trial tests how well pirtobrutinib and mosunetuzumab work in ...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-11-17
Trial ID
NCT06948786
This is a first-in-human Phase 1a/1b multicenter, open-label study designed...
Status
Recruiting
Location
City of Hope
Start Date
2022-04-13
Trial ID
NCT05131022
Treatments Being Tested
This phase II trial studies ibrutinib with or without rituximab in treating...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2013-12-06
Trial ID
NCT02007044
Treatments Being Tested
This phase II trial studies the side effects of acalabrutinib, obinutuzumab...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-12-02
Trial ID
NCT06054776
This study aims to utilize anti-CD20 monoclonal antibodies to eliminate per...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT07574073
Treatments Being Tested
This phase II trial studies how well zanubrutinib and rituximab work in tre...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-05-26
Trial ID
NCT04458610
Treatments Being Tested